Close

BridgeBio Pharma (BBIO) PT Lowered to $37 at Goldman Sachs

March 24, 2020 12:48 PM EDT Send to a Friend
Goldman Sachs analyst Paul Choi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login